Bacteria engineered to treat metabolic diseases
US11291693B2 · kind B2 · utility
6Cited by
20References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2016 |
| Grant date | Apr 5, 2022 |
| Priority date | — |
| Expiry date | Jul 22, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of attenuating metabolic diseases are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.